Global Legionella Testing Market Overview to 2027

DUBLIN, June 20, 2022 /CNW/ -/PRNewswire/ —

The report “Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027” has been added to from offer.

The global legionella test market has reached a value of US$261 million in 2021. Looking ahead, the publisher expects the market to reach US$424 million by 2027, posting a CAGR of 8.38% over the period 2022-2027. Keeping in mind the uncertainties of COVID-19, we continuously monitor and assess the direct and indirect influence of the pandemic on different end-use sectors. This information is included in the report as a major market contributor.

Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms. Its tests identify the existence of bacteria or antigens in the blood, urine and sputum. Currently, various test methods are available to diagnose Legionella disease, including urinary antigen, paired serology, polymerase chain reaction (PCR), direct fluorescent antibody (DFA) staining, and culture of secretions. lower respiratory tract. According to the test results, macrolides, quinolones, tetracycline, doxycycline, minocycline, trimethoprim, and other antibiotic treatments are usually given to patients.

Adults over 50 are more likely to develop Legionella. Hence, increasing geriatric population globally represents one of the major factors positively influencing the market. Additionally, the growing number of people who smoke and have cancer, diabetes, kidney disease, human immunodeficiency virus (HIV) or other chronic illnesses are at risk of infection and hospitalization.

Since the death rate of Legionella is high, there is an increase in demand for its diagnostic tests and effective treatments. Furthermore, the bacteria responsible for Legionella are mainly found in different natural and man-made aquatic environments, such as cooling towers, respiratory therapy equipment, fountains, misting devices, spa pools and water systems in hotels, homes and factories. As a result, health agencies in many countries are developing an effective Water Safety Plan (WSP) to minimize the growth of Legionella in water.

This, in turn, increases the demand for Legionella testing in work buildings to comply with legislation. Additionally, recent clinical trials on diagnostic and treatment strategies for adult patients with community-acquired pneumonia are contributing to the growth of the market.

Competitive Landscape:

The competitive landscape of the industry was also reviewed with some of the major players being Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc, Eiken Chemical Co. Ltd, Quidel Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.

Key questions answered by this report:

  • How has the global legionella test market behaved so far and how will it behave in the coming years?
  • What has been the impact of COVID-19 on the Global Legionella Testing Market?
  • What are the main regional markets?
  • What is the market breakdown by application?
  • What is the market breakdown by end user?
  • What are the different stages of the industry value chain?
  • What are the key drivers and challenges in the industry?
  • What is the structure of the global legionella testing industry and who are the key players?
  • How competitive is the industry?

Main topics covered:

1 Preface

2 Scope and methodology

3 Executive summary

4 Presentation
4.1 Overview
4.2 Key Industry Trends

5 Global Legionella Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakdown by Application
6.1 Water analysis
6.1.1 Market trends
6.1.2 Market Breakdown by Type Microbial culture DFA staining PCR Others
6.1.3 Market Forecast
6.2 IVD testing
6.2.1 Market trends
6.2.2 Market Breakdown by Type Blood culture Urine antigen test DFA staining PCR Others
6.2.3 Market Forecast

7 Market Breakdown by End User
7.1 Diagnostic laboratories
7.1.1 Market trends
7.1.2 Market Forecast
7.2 Hospitals and clinics
7.2.1 Market trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market trends
7.3.2 Market Forecast

8 Market Breakdown by Region

9 SWOT Analysis

10 Value chain analysis

11 Porter’s Five Forces Analysis

12 Price Analysis

13 Competitive landscape
13.1 Market structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories Company overview Product Portfolio Finance SWOT Analysis
13.3.2 Becton, Dickinson and company Presentation of the company Product portfolio Finance SWOT Analysis
13.3.3 BioMérieux SA Company overview Product Portfolio Finance SWOT Analysis
13.3.4 Bio-Rad Laboratories Inc. Company Overview Product Portfolio Finance SWOT Analysis
13.3.5 Eiken Chemical Co. Ltd Company Overview Product portfolio Finance
13.3.6 Quidel Company Company Overview Product Portfolio Finance SWOT Analysis
13.3.7 Takara Bio Inc. Company Overview Product portfolio financial statements
13.3.8 Thermo Fisher Scientific Inc. Company Overview Product portfolio Finance SWOT Analysis

For more information on this report, visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets

Lance B. Holton